Coverage
-
July 09, 2021
A Massachusetts federal judge refused Friday to toss Akebia Therapeutics Inc.'s lawsuit challenging the Centers for Medicare & Medicaid Services' exclusion of its kidney disease drug under Medicare Part D for certain uses, finding the exclusion constitutes a final agency action that can be challenged in court.
1 other articles on this case.
View all »